Advertisements



Two Catalysts For Axovant Sciences In March

Two Catalysts For Axovant Sciences In March.....»»

Category: topSource: seekingalphaFeb 11th, 2019

Gilead Sciences (GILD) Q1 Earnings Top Estimates

Gilead (GILD) delivered earnings and revenue surprises of 8.64% and -0.49%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Want the latest recommendations from Zack.....»»

Category: dealsSource: nytMay 2nd, 2019

PRA Health Sciences (PRAH) Surpasses Q1 Earnings Estimates

PRA Health Sciences (PRAH) delivered earnings and revenue surprises of 3.77% and -1.49%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Want the latest recommendations from Zacks In.....»»

Category: dealsSource: nytMay 1st, 2019

Gilead’s CFO to step down early next year

Foster City-based Gilead Sciences/ longtime chief financial officer is planning her exit. Robin Washington, the biopharmaceutical giant’s executive vice president and CFO, intends to retire from her role by March 1, 2020, the company said. “Dur.....»»

Category: topSource: bizjournalsMay 1st, 2019

Eric Schmidt, Diane Greene exiting Alphabet"s board

Alphabet Inc. said on Tuesday that its former CEO and chairman, Eric Schmidt, and former Google Cloud CEO Diane Greene are leaving its board of directors. Robin Washington, who is retiring as chief financial officer of Gilead Sciences next March, is.....»»

Category: topSource: bizjournalsApr 30th, 2019

Gilead"s CFO, appointed to Google parent"s board, to retire

Gilead Sciences Inc. said late Tuesday Chief Financial Officer Robin Washington plans to retire in March 2020. Washington will continue as CFO while the company searches for a replacement, Gilead said. If Gilead names a CFO before March 2020, Washington .....»»

Category: topSource: marketwatchApr 30th, 2019

Gilead"s CFO, appointed to Google parent"s board, to retire

Gilead Sciences Inc. said late Tuesday Chief Financial Officer Robin Washington plans to retire in March 2020. Washington will continue as CFO while the company searches for a replacement, Gilead said. If Gilead names a CFO before March 2020, Washington .....»»

Category: topSource: marketwatchApr 30th, 2019

Why Shares of Plug Power Skyrocketed 34% in March

A range of catalysts helped power this fuel cell leader's stock higher this month......»»

Category: topSource: foxnewsApr 4th, 2019

Liberty Health Sciences: Stock Catalysts In The Lead

Liberty Health Sciences: Stock Catalysts In The Lead.....»»

Category: topSource: seekingalphaApr 4th, 2019

1 High-Yield Dividend Stock to Consider Buying Before March Ends

This pipeline giant has quite a few catalysts coming in April......»»

Category: topSource: foxnewsMar 23rd, 2019

SELLAS Life Sciences Reports 2018 Financial Results and Provides Business Update

NEW YORK, March 22, 2019 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the "Company"), a clinical-stage biopharmaceutical company focused on the.....»»

Category: earningsSource: benzingaMar 22nd, 2019

The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 13) read more.....»»

Category: blogSource: benzingaMar 14th, 2019

Mid-Day Market Update: NASDAQ Rises Over 100 Points; Axovant Sciences Shares Surge

Midway through trading Monday, the Dow traded up 0.16 percent to 25,512.72 while the NASDAQ climbed 1.37 percent to 7,522.91. The S&P also rose, gaining 0.85 percent to 2,772.23. Leading and Lagging Sectors read more.....»»

Category: blogSource: benzingaMar 11th, 2019

Stocks That Fell to 3-Year Lows in the Week of March 8

Gilead Sciences, CVS Health, Walgreens and Vodafone reach multiyear lowsRelated Stocks: GILD, CVS, WBA, VOD,.....»»

Category: personnelSource: nytMar 8th, 2019

Axovant Sciences hires CMO of Allergan to join Axovant as EVP of R&D

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 30th, 2018

Axovant Sciences: Breaking Down What"s Seemingly Broken For Further Insight

Axovant Sciences: Breaking Down What"s Seemingly Broken For Further Insight.....»»

Category: topSource: seekingalphaMay 31st, 2018

Axovant Sciences appoints Fraser Wright, PhD as Chief Technology Officer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 6th, 2018

Axovant Sciences licenses OXB-102 from Oxford BioMedica

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 6th, 2018

UPDATE: Axovant shares soar 51% premarket on $842.5 mln licensing pact for Parkinson"s treatment

Shares of Axovant Sciences Ltd......»»

Category: topSource: marketwatchJun 6th, 2018

Axovant Sciences, Oxford BioMedica agree to $842.5M OXB-102 license agreement

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 6th, 2018

Axovant Sciences to hold a conference call

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 6th, 2018